Neuroleptics, the most widely prescribed group of psychotropic drugs, are indispensable in the management of a majority of patients with schizophrenia, as well as other psychoses, yet they have not proved to be an unmixed blessing. They are associated with troublesome adverse effects, of which movement disorders are the most serious in terms of frequency, persistence and overall impact on the well-being of patients and care-givers. This book was prepared with the aim of improving understanding and clinical management of these iatrogenic conditions. It deals with historical, clinical and neurobiological aspects of tardive dyskinesia and related movement disorders such as parkinsonism, dystonia and akathisia. Sections are also devoted to the measurement of tardive dyskinesia, to geographical and ethnic differences, and to management with novel neuroleptic agents and biofeedback. With authoritative contributions and an international perspective, this book will be valuable to clinicians and researchers alike in psychiatry, neurology and related disciplines.
"synopsis" may belong to another edition of this title.
Although generally beneficial, neuroleptics often cause adverse effects, of which movement disorders are the most serious in terms of frequency and persistence. This book was prepared with the aim of improving understanding and clinical management of these treatment-caused conditions. The authors address the historical, clinical and neurobiological aspects of the most serious of these conditions, tardive dyskinesia, as well as related movement disorders such as parkinsonism, dystonia and akathisia. The authors also devote sections of the text to the measurement of tardive dyskinesia, geographical and ethnic variables, and management with novel neuroleptic agents and biofeedback.
"This is an excellent new book...Written and edited by internationally recognized experts in the field, this book is a valuable contribution to psychiatry...Any clinician who is involved in the treatment of patients with chronic psychoses should read and refer to this book." Michael J. Schrift, Doody's Health Sciences Book Review Journal
"The book enhances our understanding of TD's neurobiological basis, and thus, it might help us to find new antipsychotics with anti-dyskinetic properties and other treatment strategies that could be used in the management of TD....this text is a comprhensive reference for researchers, psychiatrists and neurologists. It would be a useful addition to departmental and academic libraries." R. Ramasubbu, MD, FRCPC, Annals RCPSC
"This will be helpful for residents, fellows, practicing psychiatrists, researchers, and clinical neurologists with interest in Movement Disorders....the authors should be congratulated for completing the great task of writing this book..." S. Das, The Canadian Journal of Neurological Sciences
"About this title" may belong to another edition of this title.
£ 85.14 shipping from U.S.A. to United Kingdom
Destination, rates & speeds£ 55.53 shipping from U.S.A. to United Kingdom
Destination, rates & speedsSeller: Solr Books, Lincolnwood, IL, U.S.A.
Condition: new. Seller Inventory # BCV.0521433649.N
Quantity: 1 available
Seller: HPB-Red, Dallas, TX, U.S.A.
hardcover. Condition: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority! Seller Inventory # S_396676276
Quantity: 1 available
Seller: Mispah books, Redhill, SURRE, United Kingdom
Hardcover. Condition: Like New. Like New. book. Seller Inventory # ERICA77305214336496
Quantity: 1 available
Seller: BWS BKS, Ferndale, NY, U.S.A.
Hardcover. Condition: New. *** FREE UPGRADE to Courier/Priority Shipping Upon Request *** *** IN STOCK AND IMMEDIATELY AVAILABLE FOR SHIPMENT - FLAWLESS COPY, BRAND NEW, PRISTINE, NEVER OPENED -- with a bonus offer--. Seller Inventory # 37971
Quantity: 2 available